Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2025-12-24 @ 11:50 AM
NCT ID:
NCT03600961
Eligibility Criteria:
Inclusion Criteria:
* Subject is ≥18 years of age
* Subject must sign a Patient Informed Consent (PIC) or a Patient Data Release Form (PDRF)
* Subject must agree to undergo all required follow-up visits
Exclusion Criteria:
* Pregnant and/or breast feeding females at the time of enrolment
* Known allergies to Acetylsalicylic Acid (ASA), clopidogrel, ticlopidin, heparin or any other anticoagulant
/antiplatelet required for PCI, contrast medium, sirolimus, or similar drugs, or the stent materials that cannot be adequately pre-medicated
* Currently participating in another study that has not yet reached the primary endpoint
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03600961
Study Brief:
Protocol Section:
NCT03600961